Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Tempest Therapeutics announced clinical updates from its ongoing Phase 1 trials of TPST-2003, a dual-targeting CD19/BCMA CAR-T therapy. The updated data show a 100% complete response rate among 15 CAR-T-naïve efficacy evaluable patients treated in the REDEEM-1 and POEMS-1 trials for relapsed/refractory multiple myeloma and POEMS syndrome, respectiv…
Madrigal Pharmaceuticals announced first-quarter 2026 financial results demonstrating a 127% year-over-year increase in net sales of its key drug Rezdiffra, reaching $311.3 million. The company highlighted strong patient adoption, with over 42,250 patients on Rezdiffra, and expanded its pipeline through a global licensing agreement for a clinical-s…
Tonix Pharmaceuticals announced an agreement with a major group purchasing organization to provide commercial payer coverage for TONMYA® (cyclobenzaprine HCl sublingual tablets), a first-in-class FDA-approved non-opioid treatment for fibromyalgia in adults. The agreement grants access to around 35 million commercial lives in the U.S., representing …
U.S. Energy Corp. (NASDAQ: USEG) has been selected to participate in the inaugural Emerging Company Pavilion at the 31st Annual Sohn Investment Conference on May 12, 2026. This selection recognizes the company's growth trajectory and market potential, offering exposure to leading institutional investors and enhancing its profile in helium, carbon m…
KVH Industries announced its Q1 2026 results with revenues up 27% year-over-year to $32.3 million, driven primarily by a 30% increase in service revenue led by growth in low Earth orbit (LEO) satellite service sales from Starlink and OneWeb. The company reported a net income of $0.6 million, compared to a loss in the prior year period, and a substa…
Sprott Inc. reported a 9% increase in Assets Under Management (AUM) to $65.1 billion for Q1 2026, driven by market appreciation and net inflows, especially in precious metals and critical materials funds. Revenues and net income significantly increased compared to Q1 2025, supported by higher management fees, carried interest, and ETF expansion, in…
Geron Corporation announced an 8% increase in net revenue for its approved blood cancer drug RYTELO in Q1 2026 compared to Q4 2025, driven by higher demand and expanded ordering accounts. The company reaffirmed its 2026 revenue and expense guidance, highlighted progress in European commercial strategy and clinical trials, and strengthened its leade…
Kymera Therapeutics, a clinical-stage biotech company focused on targeted protein degradation therapies for immunological diseases, announced participation in two upcoming investor conferences in May 2026. The company will hold fireside chats at the Bank of America and RBC Capital Markets healthcare conferences, with live webcasts available on thei…
Energous Corporation, a Nasdaq-listed leader in over-the-air wireless power networks, announced its participation in a fireside chat at Planet MicroCap Las Vegas 2026. The event will feature key executives discussing the company’s strategy and growth, providing an opportunity for investor engagement and visibility in the microcap community.
BioCryst Pharmaceuticals announced its first quarter 2026 financial results highlighting an 11% year-over-year increase in net revenue for ORLADEYO to $148.3 million. The company also revealed a $70 million upfront licensing agreement with Neopharmed Gentili for the European commercial rights to navenibart, with potential milestone payments up to $…
EyePoint, Inc. announced its first quarter 2026 financial results highlighting ongoing Phase 3 clinical trials for its lead product candidate DURAVYU in wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME). The company expects topline data for wet AMD trials starting mid-2026 and anticipates completing enrollment for DME …
Immunocore Holdings plc reported a 14% year-over-year increase in Q1 2026 net sales of its lead product, KIMMTRAK, reaching $106.7 million globally. Landmark five-year survival data presented at AACR 2026 demonstrated that KIMMTRAK doubles the likelihood of survival in metastatic uveal melanoma patients. The company is progressing multiple Phase 3 …
Marex Group plc, listed on Nasdaq under the ticker MRX, announced record financial results for Q1 2026, highlighting substantial revenue and profit growth across all business segments. The diversified financial services firm benefited from elevated market volatility, strong client demand, and strategic acquisitions, leading to a 48% increase in rev…
Kamada Ltd., a global biopharmaceutical company specializing in plasma-derived therapies, announced it will release its first quarter 2026 financial results on May 13, 2026, prior to U.S. market open. Management will host a conference call to discuss these results and provide updates on the company's operations and growth strategies.
TScan Therapeutics reported Q1 2026 financial results along with a major corporate update highlighting important upcoming milestones. The company plans initiation of a Phase 3 study for its lead TCR-T therapy candidate TSC-101 in Q2 2026 and expects early data from the ALLOHA Phase 1 trial. Further, Phase 1 studies for new candidates TSC-102-A01 an…
Steven Madden, Ltd. announced first quarter 2026 results with an 18% revenue increase driven by strong brand momentum and direct-to-consumer growth. The company raised its fiscal 2026 revenue guidance to a 10-12% increase and introduced earnings per share guidance between $2.55 and $2.65, signaling confidence in top- and bottom-line growth despite …
UBS upgraded its rating on Galenica from "sell" to "neutral" while leaving its CHF85 price target intact. The target sits slightly above the stock's current trading level of CHF82.05, implying roughly 4% upside. The broker's move follows about a 20% fall in the share price since late February and reflects UBS's revised assessment of buy-side sentim…
Global markets rallied after media reports suggested the United States and Iran are close to agreeing a one-page memorandum that would include unblocking the Strait of Hormuz. Oil prices fell sharply, while equity indexes from Wall Street to Asia hit fresh highs on hopes of reduced Gulf tensions and stronger AI-driven demand. At the same time, long…
Natural Resource Partners L.P. released its first quarter 2026 financial results, highlighting $19.6 million in net income and declaring a $0.75 per common unit distribution. The company generated $33.8 million in free cash flow before a $39.2 million investment in its soda ash business. Though facing headwinds from weak coal sales volumes and over…
Passive, long-only vehicles bought $12.0 billion of emerging-market equities in April, with Taiwan, Brazil and China the largest recipients of inflows, Morgan Stanley reports. Active foreign managers were net sellers. Hedge funds concentrated exposure in Information Technology across Asia ex-Japan, while long-only investors adjusted regional and se…
Walt Disney reported adjusted earnings-per-share of $1.57 and revenue of $25.2 billion for the January-March quarter, beating analysts' expectations. New CEO Josh D'Amaro, in a letter to shareholders, reaffirmed the company’s outlook for accelerated adjusted EPS growth in fiscal 2026 and sustained double-digit growth into fiscal 2027, while outlini…
Morgan Stanley's analysis of Ministry of Transportation and industry data shows air passenger traffic in China declined 5.7% year-over-year over the May 1-5 Labor Day holiday, even as total passenger movements increased 3.5%. Rail and road travel posted year-over-year gains, while air ticket prices rose sharply and parcel volumes weakened.
Brazil Potash Corp. has awarded the Front-End Engineering Design (FEED) contract for critical surface facilities and infrastructure of its Autazes potash project in Amazonas, Brazil to a consortium of Wood and Promon Engenharia. This milestone is essential for securing construction debt financing from Development Finance Institutions and Export Cre…
Deutsche Bank has moved Telecom Plus from 'buy' to 'hold' and cut its price target to 1300p from 2000p. The revision comes amid concerns that the company's word-of-mouth multiservice acquisition model is under strain; the news coincided with a notable drop in the stock price on the day of the update.
The USDA weekly Crop Progress snapshot shows corn planting 38% complete, level with last year and modestly ahead of the recent average, while soybean planting is at 33%, outpacing last year by 5% and the recent average by 10%. Emergence for both crops sits at 13% and futures have rallied, with corn contracts reaching multi-month highs and soybeans …
